Skip to main content
Clinical Trials/NCT03712462
NCT03712462
Completed
Not Applicable

Improving Weight Loss Outcomes for Binge Eating Disorder.

Drexel University1 site in 1 country126 target enrollmentAugust 20, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eating Disorder
Sponsor
Drexel University
Enrollment
126
Locations
1
Primary Endpoint
Weight Loss
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims to develop and evaluate the efficacy of a behavioral weight loss treatment approach for individuals with binge eating disorder to both reduce their binge eating behaviors and lose weight.

Detailed Description

In the current study, we propose to (a) compare the efficacy of an acceptance-based behavioral treatment (ABBT) that targets both binge eating and weight loss in patients with binge eating disorder (BED) to a Standard Behavioral Weight Loss Treatment (SBT), (b) evaluate the extent to which ABBT and SBT target shared maintenance factors for binge eating and overeating episodes, and (c) assess whether treatment efficacy is moderated by baseline values of constructs targeted in ABBT. Our study will be the first to evaluate an ABBT for BED designed to 1) address maintenance factors that give rise to both binge eating episodes and overeating episodes without loss of control and 2) increase adherence to BWL prescriptions.

Registry
clinicaltrials.gov
Start Date
August 20, 2018
End Date
February 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Meet the DSM-5 criteria for Binge Eating Disorder
  • Have a BMI range of 27-50kg/m2

Exclusion Criteria

  • are unable to fluently speak, write, and read English
  • are currently experiencing severe psychopathology that would limit their ability to engage in study (e.g., suicidality, substance use disorder, psychotic disorder)
  • are unable to engage in moderate physical activity (i.e., walk 2 blocks without rest)
  • have a medical condition (e.g., acute coronary syndrome, type I diabetes) that would pose a risk to the participant during intervention, cause a change in weight, or limit ability to comply with the recommendations of the program
  • Pregnant or planning to become pregnant in the next 2 years
  • Recently began a course of or changed the dosage of medication that can cause significant change in weight
  • Have a history of bariatric surgery
  • Have had weight loss of \> 5% in the past 6 months

Outcomes

Primary Outcomes

Weight Loss

Time Frame: Changes from baseline assessment (before beginning treatment), to post-treatment assessment (1 year after baseline assessment), to follow-up assessment (2 years after baseline assessment)

Between-group changes in percent weight loss from baseline 1 month, 3 months, and 6 months into the study, at post-treatment (1 year after baseline) and at the one year follow-up assessment (2 years after the baseline).

Secondary Outcomes

  • Eating Disorder Examination Questionnaire(Baseline, Post-Treatment (1 year after baseline), and 1 Year Follow-Up (2 years after baseline))

Study Sites (1)

Loading locations...

Similar Trials